Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate therapy in neutral lipid storage disease with myopathy
NL-OMON37985Phase 4Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bezafibrate in Neutral lipid storage disease with myopathy (NLSDM) (2 arms), sponsored by Maastricht University. Primary endpoints: Change in mitochondrial function, Change in cardiac lipid accumulation and 3 more. Started Aug 2011; status: active, not recruiting.
02
Drugs
bezafibrate
03
Conditions
Neutral lipid storage disease with myopathy (NLSDM)
Beyond the preview
Go deeper on NL-OMON37985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37985.